Vimarsana
Biggest News Aggregation in the World

Page 3 - Complement Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Complement Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Complement Therapeutics Today - Breaking & Trending Today

BioGeneration Ventures Closes BGV Fund V, at €150M - Vimarsana News

BioGeneration Ventures Closes BGV Fund V, at €150M

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Six biotech spinouts you should watch out for this year - Vimarsana News

Six biotech spinouts you should watch out for this year

Here are six biotech spinouts across the globe that have received funding over the past year, that you should know about.

University spinout secures £63m to tackle diseases including main cause of blindness - Vimarsana News

University spinout secures £63m to tackle diseases including main cause of blindness

CTx was spun out of the University of Manchester in 2021

Biotech Financing Roundup: Envedo Bio, Complement, Abdera, TORL & More - Vimarsana News

Biotech Financing Roundup: Envedo Bio, Complement, Abdera, TORL & More

The biggest rounds of recent biotech financings are from startups raising money to advance their research to the clinic. Here’s a look back at funding rounds from companies such as Abdera Therapeutics, Complement Therapeutics, and Enveda Biosciences.

Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases - Vimarsana News

Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases

/PRNewswire/ -- Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases,...